CD44 and neoplasm: New approaches include the use of nanomedicine to deliver drug combinations selectively at the tumor site, targeting the acidic microenvironment, a hyaluronic acid (HA) coating on the nanoparticles surface to target CD44-overexpressed tumor cells, the use of natural substances in combination with classical chemotherapy, and others [7,8].